LNTH READ THE FULL LNTH RESEARCH REPORT Lantheus Holdings, Inc. (NASDAQ:LNTH) began 2025 with a pair of potentially ...

The bureaucratic bloat in federal research funding is finally facing a long-overdue reckoning, especially for indirect ...

Catalent, Inc., the leader in enabling the development and supply of better treatments for patients worldwide, today announced that it has appointed Susan Mahony, Marie-France Tschudin and Tim Walbert ...

The treatment landscape of Inflammatory Bowel Disease (IBD) has undergone a significant transformation over the past two ...

A study published in Cell Metabolism looks at the artificial sweetener aspartame, insulin levels and blood inflammation in mice. Prof Naveed Sattar, Professor of Cardiometabolic Medicine/Honorary ...

A new study led by researchers from Boston University Chobanian & Avedisian School of Medicine has found there is no consensus in how clinical experts interpret CGM reports from people without ...

Perceive Pharma, a pharmaceutical company pioneering novel small molecule therapeutics in ophthalmology, today announced the closing of a $15M Series A funding round including Deerfield Management, ...

A phase 2 trial shows that olpasiran, an RNA-based therapy, reduces lipoprotein(a) [Lp(a)] levels by more than 95% in ...

Founder and CEO of Zander's Game House, Jeanne Slkoff, spoke about her business during Spring Semester Entrepreneur Speaker ...